# A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China

> **NCT03872830** · PHASE2 · COMPLETED · sponsor: **Shijiazhuang Yiling Pharmaceutical Co. Ltd** · enrollment: 165 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Felbinac Trometamol Injection
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03872830
- **Lead sponsor:** Shijiazhuang Yiling Pharmaceutical Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-27
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-12-05
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03872830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03872830, "A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03872830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*